Utility of PCA3 urine assay in Japanese men undergoing prostate biopsy.

被引：0
|
作者：
Okihara, K. [1 ]
Ochiai, A. [1 ]
Kamoi, K. [1 ]
Miki, T. [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Dept Urol, Kyoto, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.50
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Jose Rubio-Briones
    Angel Borque
    Luis M. Esteban
    Juan Casanova
    Antonio Fernandez-Serra
    Luis Rubio
    Irene Casanova-Salas
    Gerardo Sanz
    Jose Domínguez-Escrig
    Argimiro Collado
    Alvaro Gómez-Ferrer
    Inmaculada Iborra
    Miguel Ramírez-Backhaus
    Francisco Martínez
    Ana Calatrava
    Jose A. Lopez-Guerrero
    BMC Cancer, 15
  • [22] Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy
    Rubio-Briones, Jose
    Borque, Angel
    Esteban, Luis M.
    Casanova, Juan
    Fernandez-Serra, Antonio
    Rubio, Luis
    Casanova-Salas, Irene
    Sanz, Gerardo
    Dominguez-Escrig, Jose
    Collado, Argimiro
    Gomez-Ferrer, Alvaro
    Iborra, Inmaculada
    Ramirez-Backhaus, Miguel
    Martinez, Francisco
    Calatrava, Ana
    Lopez-Guerrero, Jose A.
    BMC CANCER, 2015, 15
  • [23] PCA3 Molecular Urine Assay Pivotal US Clinical Study Confirms Utility for Predicting Repeat Biopsy Outcome
    Groskopf, J.
    Ward, J.
    Hertzman, B.
    Bailen, J.
    Franco, N.
    Williams, T.
    Koziol, I
    Henderson, J.
    Bidair, M.
    Gittelman, M.
    UROLOGY, 2012, 80 (03) : S30 - S31
  • [24] The value of the PCA3 score in guiding prostate biopsy decision in men with a prior negative biopsy
    Haese, A.
    De La Taille, A.
    Van Poppel, H.
    Marberger, M.
    Stenzl, A.
    Mulders, P.
    Huland, H.
    Abbou, C. C.
    Joniau, S.
    Remzi, M.
    Tinzi, M.
    Feyerabend, S.
    Stillebroer, A.
    Van, Gils M.
    Schalken, J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 142 - 142
  • [25] PROSTATE BIOPSY: PATHOLOGICAL PATTERNS IN MEN WITH PROSTATE CANCER GENE 3 (PCA3) SCORE FLUCTUATIONS
    De Luca, Stefano
    Passera, Roberto
    Bollito, Enrico
    Cappia, Susanna
    Amparore, Daniele
    Cattaneo, Giovanni
    Manfredi, Matteo
    Mele, Fabrizio
    Bertolo, Riccardo
    Porpiglia, Francesco
    ANTICANCER RESEARCH, 2015, 35 (06) : 3723 - 3723
  • [26] PHI AND PCA3 SIGNIFICANTLY IMPROVE DIAGNOSTIC ACCURACY IN PATIENTS UNDERGOING PROSTATE BIOPSY
    Perdona, Sisto
    Quarto, Giuseppe
    Sorrentino, Domenico
    De Domenico, Renato
    Cariati, Federica
    Sorrentino, Alessandra
    Terracciano, Daniela
    Mazzarella, Claudia
    Marino, Ada
    Armellino, Carla
    Di Girolamo, Antonio
    Montanino, Florestano
    Vincenzo, Altieri
    Bruzzese, Dario
    Ferro, Matteo
    ANTICANCER RESEARCH, 2012, 32 (05) : 1920 - 1920
  • [27] The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization
    Eva Neumann
    Jörg Hennenlotter
    Tilman Todenhöfer
    Marcus Scharpf
    Tim Neumann
    David Schilling
    Arnulf Stenzl
    Jens Bedke
    Advances in Therapy, 2017, 34 : 966 - 974
  • [28] The Value and Evaluability of the PCA3 Urine Assay in Prostate Carcinoma is Independent of the Tumor Localization
    Neumann, Eva
    Hennenlotter, Joerg
    Todenhoefer, Tilman
    Scharpf, Marcus
    Neumann, Tim
    Schilling, David
    Stenzl, Arnulf
    Bedke, Jens
    ADVANCES IN THERAPY, 2017, 34 (04) : 966 - 974
  • [29] The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting
    Adam, Ahmed
    Engelbrecht, Matthys J.
    Bornman, Maria S.
    Manda, Samuel O.
    Moshokoa, Evelyn
    Feilat, Rasmi A.
    BJU INTERNATIONAL, 2011, 108 (11) : 1728 - 1733
  • [30] PCA3: A molecular urine prostate cancer test
    Rittenhouse, Harry
    TUMOR BIOLOGY, 2007, 28 : 50 - 50
12345